{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Prostatic_Acid_Phosphatase-Sargramostim_Fusion_Protein_PA2024",
  "nciThesaurus": {
    "casRegistry": "",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A genetically-engineered protein formed by the fusion of prostatic acid phosphatase (PAP) and sargramostim (GM-CSF). Vaccination with antigen-presenting cells (APC) loaded with prostatic acid phosphatase-sargramostim fusion protein may elicit a cytotoxic T-cell response against tumor cells that express PAP. (NCI05)",
    "fdaUniiCode": "N5E5Q8249O",
    "identifier": "C2548",
    "preferredName": "Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [
      "C1512"
    ],
    "synonyms": [
      "PA2024",
      "PROSTATIC ACID PHOSPHATASE (PAP)-GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR (GM-CSF) FUSION PROTEIN",
      "Prostatic Acid Phosphatase-Sargramostim Fusion Protein PA2024"
    ]
  }
}